Trending...
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Governor Newsom honors fallen California Highway Patrol Officer Miguel Cano
Semi-quantitative measurement of activation of human NFkB p65 in nuclear extracts or cell lysates.
MILPITAS, Calif. - Californer -- Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) represents a family of inducible transcription factors, which regulates many biological processes including immune responses, cell growth, apoptosis etc. This family includes five structurally related members namely NF-κB1 (or p50), NF-κB2 (or p52), RelA (or p65), RelB and c-Rel, which are normally sequestered in the cytoplasm by a family of inhibitory proteins and are inactive.
Upon stimulation, NF-κB proteins form homo- or heterodimers and are transported into the nucleus where they bind to specific DNA sequences of targeted genes and activate transcription. Traditionally, western blot is used to detect the expression of NFkB and electrophoretic mobility shift assay or reporter assays are used to measure the NFkB activity respectively. But some of these methods are time consuming, laborious, and require radioactivity. BioVision's NFkB RelA/p65 Transcription Factor Activity Assay is a 96-well plate based colorimetric assay to measure the activation of human NFkB p65 in nuclear extracts or cell lysates.
More on The Californer
The kit offers easy, rapid, sensitive and non-radioactive way to detect the activation of transcription factors in samples. In this assay, double stranded DNA sequence containing the NFkB p65 consensus binding site is coated on the 96-well plate. Active NFkB p65 in the cell lysate or the nuclear extract binds to the oligonucleotides on the plate. After the addition of RelA/p65 primary antibody that recognizes the NFkB p65-oligonucleotide complex, a HRP-conjugated secondary antibody is added followed by the addition of TMB substrate and a color signal is developed, which is measured at 450 nm.
Storage Conditions: Multiple Temperatures
USAGE: For Research Use Only! Not For Use in Humans
For more information on this Assay Kit Cat# K2093 https://bit.ly/3l2TzNM
Upon stimulation, NF-κB proteins form homo- or heterodimers and are transported into the nucleus where they bind to specific DNA sequences of targeted genes and activate transcription. Traditionally, western blot is used to detect the expression of NFkB and electrophoretic mobility shift assay or reporter assays are used to measure the NFkB activity respectively. But some of these methods are time consuming, laborious, and require radioactivity. BioVision's NFkB RelA/p65 Transcription Factor Activity Assay is a 96-well plate based colorimetric assay to measure the activation of human NFkB p65 in nuclear extracts or cell lysates.
More on The Californer
- California: Governor Newsom proclaims Independence Day 2025
- Gundam GQuuuuuuX Takes Center Stage at Anime Expo 2025
- John Duffy Competes in Mr Muscle Beach
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Thorn & Bloom Magazine Unveils Groundbreaking Second Edition: "Breaking the Cycle"
The kit offers easy, rapid, sensitive and non-radioactive way to detect the activation of transcription factors in samples. In this assay, double stranded DNA sequence containing the NFkB p65 consensus binding site is coated on the 96-well plate. Active NFkB p65 in the cell lysate or the nuclear extract binds to the oligonucleotides on the plate. After the addition of RelA/p65 primary antibody that recognizes the NFkB p65-oligonucleotide complex, a HRP-conjugated secondary antibody is added followed by the addition of TMB substrate and a color signal is developed, which is measured at 450 nm.
Storage Conditions: Multiple Temperatures
USAGE: For Research Use Only! Not For Use in Humans
For more information on this Assay Kit Cat# K2093 https://bit.ly/3l2TzNM
Source: BioVision Inc
0 Comments
Latest on The Californer
- Orion Retreats: Pioneering the Future of Conscious Leadership and Luxury Wellness Tourism
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- California: Governor Newsom statement on passage of Trump's "Big, Beautiful Betrayal"
- From Barrio to Transgender Pioneer: Chapter 12 of A Letter to Pawtone
- MERCURY INSURANCE NAMED ONE OF AMERICA'S GREATEST WORKPLACES FOR PARENTS & FAMILIES AND FINANCIAL SERVICES BY NEWSWEEK
- Ahead of Holiday weekend, Californians see lowest July prices at the pump in 3 years
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- Porta Potty USA Expands its Convenient Portable Restroom Rental Services Business in Montana Area
- Countrywide Fence Rental Expands its Temporary Fence Rental Business in Minnesota Area
- A Shepherd's Legacy: Honoring the Life and Impact of Pastor Ross Reinman
- California: Here's how President Trump's tax cuts for the ultra-rich will hurt YOU
- New Media Film Festival Announces Winners
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- DetailAxis Unveils it's 'Business Engine': Powerful AI Systems for Auto Appearance Pros
- California: Governor Newsom announces appointments 7.2.25
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side